Rob Davis, Merck CEO

No deal for Mer­ck and Seagen yet as talks stall over buy­out price — re­port

Two Mon­days have come and gone with­out Mer­ck’s hot­ly-ru­mored takeover of Seagen, keep­ing ob­servers wait­ing. And ac­cord­ing to a new Bloomberg re­port, that’s be­cause the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.